Approximately 1 out of 77 people in the united states of America suffer from Anemia. And as of 2004, an estimate of over 76 million people worldwide suffer from this ailment. What actually causes Anemia?
For an better overview of the causes, Anemia should be classified. The basic cause of anemia is either an increased loss or destruction of red blood cells or an impaired or decreased rate of production. An etiologic classification is based on the various conditions leading to either of these results.
Blood loss
Acute or chronic hemorrhage results in loss of plasma and all formed elements of the blood. After acute hemorrhage, the body replaces plasma within 1 to 3 days, maintaining blood volume. However, this results in a low concentration of rd blood cells, which are gradually replaced within 3 to 4 weeks. During this period there is usually a normocytic (normal size), normochromic (normal color) anemia, and there are sufficient iron sotries for hemoglobin synthesis.
In chronic blood loss, the actual number of red blood cells may be normal because of continual replacement. However, insufficient iron is available to form hemoglobin as quickly as it is lost. As a result, erythrocytes are usually small in size (microcytic and pale in color (hypochromic).
Excessive destruction
Excessive destruction or hemolysis of erythrocytes can occur from a variety of causes. One of the most common is a result of defect within the red blood cell (intracorpuscular) that shortens the life span of the cell so that production cannot keep pace with destruction. Sickle cell anemia and thalassemia, have decreased erythrocyte life spans because of a defect in hemoglobin synthesis.
Extra-corpular factors are those conditions that cause hemolysis in otherwise normal red blood cells. A classic example is erythroblastosis fetalis. Other causes can be toxic drugs, transfusion reactions, burns, poisonings (such as from lead), infections such as malaria, and splenic sequestration (hypersplenism).
Impaired or decreased production
Impaired or decreased production of red blood cells can occur as a result of either bone marrow failure or deficiency of essential nutrients. Bone marrow failure may be caused by
• Replacement of bone marrow by fibrosis or by neoplastic cells, such as in leukemia,
• Depression of marrow activity from irradiation, chemicals or drugs, or
• Interference with bone marrow activity from other systemic diseases, such as severe infection, chronic renal disease, widespread malignancy (without marrow infiltration), collage disease, or hypothyroidism.
The reason for various systemic disorders affecting erythrocyte production varies according to the condition. For example, in severe chronic infection there is evidence that depression of erythropoiesis is caused by a defect in the conversion of proteoporphyrin into hemoglobin. In addition, there is some degree of hemolysis, although the exact mechanism is not known.
The most common childhood anemia is a result of deficient iron supply, besides iron as an essential component of hemoglobin synthesis, red blood cell production is dependent on amino acids, vitamins B6, B9 and C, folic, copper and possibly cobalt. Chronic malnutrition results in anemia as a result of generalized protein. Mineral and vitamin deficiencies.
Pernicious anemia develops when the gastric mucosa fails to secrete sufficient amounts of intrinsic factor, which is essential for absorption of vitamin B12. This type of anemia is common in the elderly as a result of physiologically decreased gastric secretions. Deprived of vitamin B12, the bone marrow produces fewer but larger (macrocytic) red blood cells. The erythrocytes are usually immature and because of their extremely fragile cell membranes, are more rapidly destroyed during circulation.
Classification based on morphology
A second classification has been made that is based on the morphologic changes within the red blood cell. The major categories
1. normocytic
2. microcytic
3. macrocytic
In addition, each category may be subdivided according to the amount of hemoglobin in the cell, since hemoglobin gives the cell its characteristic red color, the usual classifications are
• normochromic
• microchromic
Classification based on Hb level
Stage I
• mild stage
• Hemoglobin level is 110-90g/l
• Erythrocyte count is 3.5-3.0×10^12/l
Stage II
• Moderate stage
• Hemoglobin level is 90-70g/l
• Erythrocyte count is 3.0-2.5×10^12/l
Stage III
• Severe stage
• Hemoglobin level is Laboratory criteria
Laboratory criteria of anemia in neonatal period are
• 0-14 days – Hemoglobin level is less than 145g/l
• 15-28days- Hemoglobin level is less than 120g/l
Posts Tagged ‘Hemolysis’
Hemolysis is the premature destruction of red blood cells (erythrocytes) and it leads to hemolytic anemia, when bone marrow activity cannot compensate for the erythrocyte loss. This condition can be caused by a large number of hereditary and acquired disorders, which number more than 200. Symptoms include anemia, breathlessness, leg ulcers and in severe cases, angina and heart failure. Treatment consists of blood transfusions for severe acute anemia, and avoiding known causes. This includes drugs, chemicals and known offending food products. Folic acid, steroids, immunoglobin, and iron therapy are commonly used, while surgical splenectomy is required rarely.
Ayurvedic treatment is aimed at treating the cause of hemolysis, reducing the anemia and treating the associated symptoms. Medicines like Punarnavadi Mandur, Tapyadi Loh, Arogya Vardhini and Lohasav are used to increase the red blood cell count. Medicines which act on the “Rakta” and “Majja” dhatus (tissues) of the body are used for this condition. These medicines include Manjishtha (Rubia cordifolia), Patol (Tricosanthe dioica), Saariva (Hemidesmus indicus), Patha (Cissampelos pareira), Musta (Cyperus rotundus), Kutki (Picrorrhiza kurroa), Guduchi (Tinosporia cordifolia) and Amalaki (Emblica officinalis).
In addition, medicines which act on the bone marrow are given in an attempt to improve the production of healthy red blood cells and also to reduce the tendency for hemolysis. These medicines include Guduchi, Amalaki, Musta, Laxadi Guggulu, Suvarna-Malini-Vasant, Heerak Bhasma and Panch -Tikta -Ghrut -Guggulu.
Additional treatment needs to be given for associated symptoms. Triphala Guggulu and Mandukparni (Centella asiatica) are used for leg ulcers. Arjuna (Terminalia arjuna) and Laxmi Vilas Ras are used for angina and heart disease.
The overall results of treatment in this condition depend upon the cause of hemolysis. However, in most of the conditions related to hemolytic anemia, the outcome is usually quite good. Acute or emergency cases need to be treated by a Hematologist.

